Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile

Table 4

Differences in immune-mediated molecules and in vitro viability rates in patients who have undergone CRRT or who did not.

	no CRRT	CRRT	value
	IL-6 (pg/mL)	59.6 (57.3–79.4)		128.8 (98.1–155.3)	0.059
IL-10 (pg/mL)	19.6 (9.8–54.6)	16.3 (7.9–86.6)	0.850
IL-8 (ng/mL)	78.1 (77.5–86.4)	119.5 (95.1–341.5)	0.038
IL-1 (pg/mL)	80.8 (45.1–233.3)	111.3 (49.8–525.6)	0.450
IFN- (pg/mL)	19.7 (17.5–30.1)	17.4 (16.9–17.8)	0.257
Viability (%)	82.8 (81.5–85.6)	83.1 (78.4–85.4)	0.775
Apoptosis (%)	15.1 (13.9–17.1)	15.8 (13.7–17.9)	0.850
Necrosis (%)	4.1 (2.2–11.5)	6.2 (3.2–12.3)	0.850